Skip to content

    ZEVRA THERAPEUTICS (ZVRA) stock price & financials

    View ZVRA earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+23.6% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $3.69M
    $12.04M
    $20.40M
    $25.88M
    $26.06M
    +605.4%
    $34.13M
    +183.4%
    $36.22M
    +77.5%
    $39.66M
    +53.3%
    Strengthening
    Operating Profit
    -$27.31M
    -$15.42M
    -$5.36M
    -$71.04M
    $4.14M
    $9.31M
    $52.15M
    $16.78M
    Strengthening
    Net Profit
    -$33.23M
    -$35.74M
    -$3.10M
    $74.71M
    -$544.0K
    +98.4%
    $12.16M
    $37.89M
    $8.75M
    -88.3%
    Weakening
    EPS
    $-0.69
    $-0.06
    $1.24
    $-0.01
    +98.6%
    $0.62
    $0.14
    -88.7%
    Weakening
    Other Income
    -$5.92M
    -$4.95M
    $3.44M
    $147.94M
    -$5.12M
    +13.5%
    $3.35M
    -$7.34M
    -313.1%
    -$3.98M
    -102.7%
    Weakening
    Interest
    $2.31M
    $2.19M
    $1.97M
    $2.01M
    $2.05M
    -11.3%
    $1.95M
    -11.2%
    $1.71M
    -13.1%
    $0
    -100.0%
    Weakening
    Depreciation
    Profit before Tax
    -$33.23M
    -$20.37M
    -$1.92M
    $76.91M
    -$977.0K
    +97.1%
    $12.67M
    $44.80M
    $12.79M
    -83.4%
    Weakening
    MarginsOPM
    -739.0%
    -128.0%
    -26.3%
    -274.5%
    15.9%
    27.3%
    144.0%
    42.3%
    Strengthening
    Tax
    0.0%
    -75.5%
    -61.7%
    2.9%
    44.3%
    4.0%
    15.4%
    31.6%
    +1004.5%
    Strengthening
    ReturnsROIC
    8.9%
    9.5%
    0.8%
    -19.9%
    0.1%
    -98.4%
    -3.2%
    -134.0%
    -10.1%
    -1322.7%
    -2.3%
    +88.3%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$18.41M$3.22M$4.21M$112.35M$65.47M$43.05M$33.78M$62.41M$145.32M
    Short-Term Investments$3.26M$0
    Total Current Assets$23.72M$6.97M$8.38M$115.06M$92.83M$86.94M$86.03M$223.01M$251.30M
    Net PP&E$1.75M$3.01M$2.39M$2.02M$1.78M$1.53M$1.01M$1.70M$2.31M
    Goodwill$0$4.70M$4.70M$4.70M$4.70M
    Intangibles$0$69.23M$68.99M$6.42M$5.79M
    Total Assets$26.75M$10.51M$11.21M$132.94M$115.34M$172.33M$178.13M$284.73M$302.71M
    LiabilitiesTotal Current Liabilities$12.00M$5.43M$7.54M$4.23M$12.02M$73.72M$34.06M$39.28M$48.63M
    Short-Term Debt
    Long-Term Debt$81.44M$77.34M$67.66M$5.07M$59.50M$61.93M$0
    Long-Term Leases$1.90M$1.59M$1.23M$843.0K$456.0K$372.0K$859.0K$870.0K
    Total Liabilities$93.31M$84.96M$77.62M$5.82M$40.22M$110.46M$138.46M$130.07M$85.06M
    EquityCommon Stock & APIC$3.0K$0$0$4.0K$3.0K$4.0K$5.0K
    Retained Earnings-$221.19M-$245.71M-$258.47M-$267.03M-$353.73M-$399.78M-$505.29M-$422.06M-$375.42M
    Total Equity-$66.57M-$74.46M-$66.41M$101.66M$75.12M$61.86M$39.67M$154.66M$217.65M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$54.20M-$23.74M-$1.94M$10.44M-$18.72M-$33.53M-$69.67M-$1.60M$33.40M
    Cash from Investing$33.33M$3.23M-$33.0K-$15.52M-$36.72M-$17.39M-$22.16M$18.13M$106.72M
    Cash from Financing$28.02M$4.94M$2.74M$113.11M$8.35M$28.46M$82.11M$12.06M-$42.14M
    SummaryCapital Expenditure-$21.0K-$26.0K-$33.0K-$102.0K-$93.0K-$296.0K$0-$835.0K-$775.0K
    Free Cash Flow-$54.22M-$23.76M-$1.97M$10.34M-$18.81M-$33.83M-$69.67M-$2.43M$32.62M
    FCF Margin-185.1%-14.8%36.1%-185.1%-123.2%-295.0%-2.3%24.0%

    Ratios